AU3122597A - Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases - Google Patents

Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Info

Publication number
AU3122597A
AU3122597A AU31225/97A AU3122597A AU3122597A AU 3122597 A AU3122597 A AU 3122597A AU 31225/97 A AU31225/97 A AU 31225/97A AU 3122597 A AU3122597 A AU 3122597A AU 3122597 A AU3122597 A AU 3122597A
Authority
AU
Australia
Prior art keywords
cyclooxygenase
compositions
once
mediated diseases
day treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31225/97A
Inventor
Barry Gertz
Keith Gottesdiener
Bruno Hancock
Conrad Winters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Merck and Co Inc
Original Assignee
Merck Frosst Canada and Co
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612065.4A external-priority patent/GB9612065D0/en
Application filed by Merck Frosst Canada and Co, Merck and Co Inc filed Critical Merck Frosst Canada and Co
Publication of AU3122597A publication Critical patent/AU3122597A/en
Assigned to MERCK & CO., INC., MERCK FROSST CANADA & CO. reassignment MERCK & CO., INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: MERCK & CO., INC., MERCK FROSST CANADA INC.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31225/97A 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases Abandoned AU3122597A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1789196P 1996-05-17 1996-05-17
US60017891 1996-05-17
GBGB9612065.4A GB9612065D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxtgenase-2 mediated diseases
GB9612065 1996-06-10
PCT/US1997/007985 WO1997044027A1 (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (1)

Publication Number Publication Date
AU3122597A true AU3122597A (en) 1997-12-09

Family

ID=26309473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31225/97A Abandoned AU3122597A (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Country Status (3)

Country Link
AU (1) AU3122597A (en)
CA (1) CA2254121A1 (en)
WO (1) WO1997044027A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
CO5280224A1 (en) * 2000-02-02 2003-05-30 Univ Florida State Res Found SUBSTITUTED TAXANS WITH ESTER IN C7, USEFUL AS ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT1534305E (en) 2003-05-07 2007-02-28 Osteologix As Treating cartilage / bone conditions with water-soluble strontium salts

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
WO1997044027A1 (en) 1997-11-27
CA2254121A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
HRP970262A2 (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU7250294A (en) Treatment of multidrug resistant diseases
AU2092697A (en) Combinations for treatment of proliferative diseases
AU2176395A (en) Compositions for treatment of diabetic complications
AU4582797A (en) Methods for treatment of retinal diseases
AU7867994A (en) Hemofiltration of mediator-related diseases
AU2429397A (en) Polymerized staphylococcal protein a for treatment of diseases
AU4067697A (en) Therapeutic compositions for treatment of cancer
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
AU2935597A (en) Therapeutic treatment for vegf related diseases
AU3107197A (en) Medicinal compositions for treating liver diseases
AU2180097A (en) Composition for prevention and treatment of periodontal diseases
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2027495A (en) Pharmaceutical composition for treating hemorrhoidal diseases
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
AU4215499A (en) Treatment of neurodegenerative diseases
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU3122597A (en) Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
AU697193B2 (en) Antiseptic dermatological composition and process for its manufacture
AU5699396A (en) Compositions for the treatment of skin conditions
AU4546096A (en) Treatment of waste